GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Smart Money Is Betting Big In NVO Options
EU Antitrust Regulators Expected to Approve Novo Holdings' $16.5B Acquisition of Catalent Without Conditions
Sanofi Becomes Latest Drugmaker to Challenge HHS Over 340B Drug-discount Program
How Is The Market Feeling About Viking Therapeutics?
Market Climbs, Bitcoin Close to $100k | Live Stock
Demon One : I'm looking forward to it ...